In this review
Choose the actual product before using the price range
The semaglutide page names a semaglutide/B12 injection at $350–$520 per treatment and says the price changes as the prescribed dose changes. Tirzepatide/B12 is listed at $390–$490 per session, with monthly treatment described. Neither range is a permanent all-dose quote. [5] [6]
The actual order needs its formulation, quantity, dispensing pharmacy and next charge. A free consultation headline does not settle every testing or recurring fee. Compare the selected first and refill purchases on the same basis.
Compare the selected first and refill costs in the complete treatment-cost planner.
Sublingual drops are a separate finished preparation
The $400 oral offer describes semaglutide drops held under the tongue, while other wording calls oral semaglutide FDA approved. The product also describes a specially compounded suspension. That does not identify the supplied drops as an approved finished medicine. [7]
FDA explains that compounds do not undergo its premarket review and reserves their use for needs an approved medicine cannot meet. A shared ingredient does not transfer an approved tablet or injection’s outcomes to a sublingual preparation. Confirm the product identity before treating the route as simply a more convenient version. [4] [8]
Keep the finished preparation attached to the evidence across GLP-1 formulations.
The written prescription must resolve the website’s contradictions
The opened injectable panels contain conflicting frequency language, and the oral description mixes volume and mass terminology. Those are material reasons to obtain clear patient-specific instructions from the prescriber and pharmacy. The public page should not be used to calculate an administration schedule. [5] [6] [7]
The injectable pages describe a monthly follow-up questionnaire before a prescription for the next course. Confirm who reviews it and how concerns reach the treating professional. A questionnaire-based process is not a promise of an immediate response or automatic renewal approval.
Discuss the follow-up need alongside the evidence on nausea and clinical follow-up.
A pharmacy label is not approval or an outcome guarantee
Mojoon promotes pharmacy regulatory categories and includes branded-trial weight-loss figures alongside its compound offers. It does not identify the actual dispenser for every order or establish that the finished compounds reproduce those trials. The page’s quality-assurance wording cannot replace the actual prescription and pharmacy label. [5] [6]
FDA distinguishes lawful compounding for a medical need from its approval review. Do not treat a facility badge, a clinician’s prescription or a familiar ingredient as a guarantee of safety, effectiveness or branded equivalence. [4] [8]
Distinguish study products and outcomes with the semaglutide and tirzepatide trial comparison.
Bilingual coordination should include the clinical relationship
The homepage advertises Chinese-English service, and the product pages describe online questionnaire review. The terms place medical care with a separate professional practice and limit access by state and service. Confirm who prescribes, the actual consultation format and where follow-up happens. [1] [2]
A language-access feature can be useful without establishing the quality of every consultation. The important handoff is from clear communication to a defined clinical and pharmacy relationship, including any additional evaluation or testing.
Compare actual care models in our provider comparisons.
Cancel before shipping, with the agreement in hand
The published refund policy allows cancellation and a refund before medication ships, while excluding returns once sent. A possible fulfillment error is referred to support for investigation. This is not a general treatment-results guarantee. [3]
The current terms refer to earlier payment and program rules without reproducing them in full. Obtain the applicable renewal, cancellation method and fee schedule before paying. No universal advance-notice interval or complete recurring total should be inferred from the free-consultation message. [2]
For a separate membership and prescription model, read our Mochi review.
Compare after the unresolved details have answers
Mochi offers a different membership and prescription arrangement; MEDVi provides another compound-versus-branded purchase comparison. Their advertised minima buy different services and cannot establish that one is cheaper without matched selected quotes.
Mojoon is relevant when bilingual coordination meets an actual need. I would keep the purchase on hold until the prescriber supplies coherent instructions, the pharmacy is identified and the complete charge and exit terms are clear. The catalogue’s convenience does not resolve those gaps.
For another remote-care purchase and its refund terms, compare our MEDVi review.
Understanding the cost
Semaglutide/B12 injection advertised at $350–$520 per treatment, with monthly courses and dose-related price adjustments. Tirzepatide/B12 lists $390–$490 per session and monthly treatment. Sublingual semaglutide drops list $400 without a settled complete recurring quote. Confirm selected quantity, pharmacy, testing, refill charge and all fees. [5] [6] [7]
Build your cost estimateSources
- Mojoon: current Chinese-language homepage and bilingual-service description
- Mojoon: January 1, 2026 terms, state access, separate care and incomplete remaining-terms reference
- Mojoon: April 1, 2023 refund policy, cancellation before shipping and no prescription returns
- FDA: compounded medicines and premarket review
- Mojoon: compounded semaglutide/B12, dose-dependent price and actual opened follow-up details
- Mojoon: compounded tirzepatide/B12, price range and actual opened follow-up details
- Mojoon: sublingual semaglutide drops and actual opened inclusion panel
- FDA: October 1, 2026 concerns with unapproved GLP-1 medicines
This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.